evans blue has been researched along with Becker Muscular Dystrophy in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davidson, AE; Dowling, JJ; Horstick, E; Hur, J; Jackson, SW; Li, X; Waugh, TA | 1 |
Assereto, S; Bonetto, A; Bonuccelli, G; Bruno, C; Cilli, M; Gazzerro, E; Lisanti, MP; Minetti, C; Pistorio, A; Scarfì, S; Sotgia, F; Zara, F | 1 |
Hoey, AJ; Laws, N; Loch, D; Trebbin, A; Van Erp, C | 1 |
Durbeej, M; Gawlik, KI; Oliveira, BM | 1 |
Grounds, MD; Klyen, BR; Radley-Crabb, HG; Sampson, DD; Shavlakadze, T | 1 |
Adamo, CM; Adams, ME; Beavo, JA; Froehner, SC; Percival, JM; Whitehead, NP | 1 |
Carbonetto, S; Chakkalakal, JV; Chin, E; Harrison, MA; Jasmin, BJ; Michel, RN | 1 |
Benabdallah, BF; Bouchentouf, M; Mills, P; Tremblay, JP | 1 |
Ferretti, R; Marques, MJ; Minatel, E; Neto, HS; Vomero, VU | 1 |
McClure, WC; Ogawa, H; Rabon, RE; Tseng, BS | 1 |
10 other study(ies) available for evans blue and Becker Muscular Dystrophy
Article | Year |
---|---|
Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.
Topics: Animals; Base Sequence; Birefringence; Calcium; Disease Models, Animal; Drug Evaluation, Preclinical; Dystrophin; Embryo, Nonmammalian; Evans Blue; Fluoxetine; Gene Expression Profiling; Gene Knockdown Techniques; Homeostasis; Molecular Sequence Data; Morpholinos; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Oligonucleotide Array Sequence Analysis; Phenotype; Serotonin Plasma Membrane Transport Proteins; Stress, Mechanical; Survival Analysis; Zebrafish | 2014 |
Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies.
Topics: Animals; Boronic Acids; Bortezomib; Disease Models, Animal; Dystroglycans; Evans Blue; Gene Expression Regulation; Glycoproteins; Mice; Mice, Inbred C57BL; Muscular Dystrophy, Duchenne; Mutation; Proteasome Inhibitors; Pyrazines; Sarcoglycans; Ubiquitin | 2010 |
Timeline of cardiac dystrophy in 3-18-month-old MDX mice.
Topics: Aging; Animals; Aorta, Thoracic; Cardiomyopathies; Coloring Agents; Evans Blue; Fibrosis; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocardium; Phosphorylation; RNA, Messenger; Smad2 Protein; Time Factors; Transforming Growth Factor beta | 2010 |
Transgenic expression of Laminin α1 chain does not prevent muscle disease in the mdx mouse model for Duchenne muscular dystrophy.
Topics: Animals; Animals, Genetically Modified; Biopsy; Creatine Kinase; Evans Blue; Gene Expression Regulation; Laminin; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Muscles; Muscular Dystrophy, Duchenne; Transgenes | 2011 |
Identification of muscle necrosis in the mdx mouse model of Duchenne muscular dystrophy using three-dimensional optical coherence tomography.
Topics: Animals; Coloring Agents; Disease Models, Animal; Evans Blue; Humans; Imaging, Three-Dimensional; Male; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Necrosis; Tomography, Optical Coherence | 2011 |
Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
Topics: Animals; Creatine Kinase; Cyclic GMP; Diaphragm; Disease Models, Animal; Evans Blue; Fibrosis; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Contraction; Muscle Fatigue; Muscle Weakness; Muscular Dystrophy, Duchenne; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2012 |
Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
Topics: Animals; Calcineurin; Cell Membrane; DNA-Binding Proteins; Dystrophin; Evans Blue; Macrophage-1 Antigen; Mice; Mice, Inbred mdx; Mice, Transgenic; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NFATC Transcription Factors; Nuclear Proteins; Sarcolemma; Signal Transduction; Transcription Factors; Utrophin | 2004 |
Exercise improves the success of myoblast transplantation in mdx mice.
Topics: Animals; Animals, Newborn; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Dystrophin; Elapid Venoms; Evans Blue; Graft Survival; Green Fluorescent Proteins; Male; Mice; Mice, Inbred mdx; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myoblasts; Physical Conditioning, Animal; Tissue Transplantation; Treatment Outcome | 2006 |
Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy.
Topics: Aging; Animals; Cell Nucleus; Disease Models, Animal; Disease Progression; Dystrophin; Evans Blue; Laryngeal Muscles; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Fibers, Skeletal; Muscular Dystrophy, Duchenne; Necrosis; Regeneration | 2007 |
Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice.
Topics: Age Factors; Amidinotransferases; Animals; Coloring Agents; Creatine; Disease Models, Animal; Energy Metabolism; Evans Blue; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation, Enzymologic; Guanidinoacetate N-Methyltransferase; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Motor Activity; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Up-Regulation | 2007 |